Health Evidence Network synthesis report 53
World's largest Science, Technology & Medicine Open Access book publisher
Chapter 7 from the book People's Movements in the 21st Century - Risks, Challenges and Benefits
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
An analysis from the perspective of the health sector in Latin America and the Caribbean
Washington, D.C., 2017
Weekly epidemiological record/ Relevé épidémiologique hebdomadaire 4 AUGUST 2017, 92th YEAR / 4 AOÛT 2017, 417-436
Guía para países de bajos ingresos. 2 edición
Topics in Antiviral Medicine 25 Issue 2 May/June 2017
Октябрь 2017
Русский
Рекомендации EACS 9.0
Guide pour les pays à faibles revenus.
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more